Skip to ContentSkip to Navigation
Practical matters How to find us A.S.S. (Alexander) Dömling, Prof Dr

A.S.S. (Alexander) Dömling, Prof Dr

Professor and chair Drug Design Group

Expertise

D ö mling belongs to top 2% of most influential researchers worldwide (Stanford-Elsevier https://elsevier.digitalcommonsdata.com/datasets/btchxktzyw/3 ). Multicomponent reaction chemistry, drug design & early development, structure-based drug design, fragment based drug design, computational drug design, proteases, protein protein interactions, receptors, missmutation, orphan disease, inflammation, cancer, metabolic disease

Other positions

Member of the faculty committee “Healthy Aging”
NWO-CW-FW study group director
Coordinator of MCB seminar series 2013/2014/2015
Cofounder of Carmolex Inc
Cofounder of Carmolex BV
Cofounder of Novel Therapeutics BV
Cofounder of Telesis Pharma BV
Last modified:25 June 2022 12.20 a.m.

Contact information

Antonius Deusinglaan 1
9713 AV Groningen
The Netherlands